Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Ling

Showing results (231-240 of 232) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 232 results.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 25, 2016
[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment
(2016 version)]Yuankai Shi, Yan Sun, Cuimin Ding, et al.
The Lancet. Respiratory Medicine|February 3, 2024
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trialHua Zhong, Shengjie Sun, Jianhua Chen, et al.
Pageof 24

Showing results (231-240 of 232) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 232 results.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 25, 2016
[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment
(2016 version)]Yuankai Shi, Yan Sun, Cuimin Ding, et al.
The Lancet. Respiratory Medicine|February 3, 2024
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trialHua Zhong, Shengjie Sun, Jianhua Chen, et al.
Pageof 24